Home > Category > > Small Molecule Compound > OR-1896

OR-1896

Glpbio

Catalog No：GC39415-25mg CAS No.：220246-81-1 MDLNo： Brand:Glpbio purity： 特性： Purpose:OR-1896 是 Levosimendan 的活性长寿代谢产物。OR-1896 是一种高选择性磷酸二酯酶 (PDE III) 抑制剂，是一种功能强大的血管扩张剂。OR-1896 可以打开 ATP 敏感的 K+ 通道，并具有 Ca2+ 致敏作用。OR-1896 可减轻心肌细胞的凋亡，心脏重塑和心肌炎症。DMSO: 62.5 mg/mL (254.81 mM)

Share

Size	Availability	Price(USD)
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	OR-1896
CAS	220246-81-1
Formula	C₁₃H₁₅N₃O₂
MW	245.28
Storage condition	Store at -20°C

Related literature

Sorry, there is no relevant literature

Related

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

Isotachysterol 3

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

9-Hydroxycamptothecin

LCKLSL hydrochloride

LCKLSL hydrochloride

LCKLSL hydrochloride

LCKLSL hydrochloride

History

OR-1896

(11bS)-4-Hydroxy-2,6-bis(4-nitrophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bS)-4-Hydroxy-2,6-bis(4-nitrophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

878111-16-1 ≥98%,99%e.e.

ARL4D Human

ARMC10 Human

(11bR)-4-Hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bR)-4-Hydroxy-2,6-bis(2,3,4,5,6-pentafluorophenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

1284293-45-3 ≥98%,99%e.e.

(11bR)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bR)-2,6-Bis(3,5-dimethylphenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

1065214-95-0 ≥98%,99%e.e.

LC3-mHTT-IN-AN1

LC3-mHTT-IN-AN1

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(2,4,6-trimethylphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(2,4,6-trimethylphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

1011465-23-8 ≥98%,99%e.e.

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

791616-65-4 ≥98%,99%e.e.

(11bR)-2,6-Bis(4-chlorophenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(11bR)-2,6-Bis(4-chlorophenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

915038-16-3 ≥98%,99%e.e.